[ad_1] Even as venture capital flows into startups pick up, more than $10 billion in committed capital is still sitting on the sidelines. The paradox […]
[ad_1] Christine Brennan, formerly at Novartis and MSD, is returning to corporate VC at Johnson & Johnson’s JJDC unit, replacing Marian Nakada. US-based pharmaceutical and […]